Persistent Asset Partners »

Aytu Biopharma shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Aytu Biopharma (AYTU) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Aytu Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Aytu Biopharma held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aytu Biopharma by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $207k 79k 2.60
2025-09-30 $117k 63k 1.88

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Molina Healthcare (MOH)
Anthem (ELV)
Intel Corporation (INTC)
Axt (AXTI)
Terns Pharmaceuticals (TERN)
Sandisk Corp (SNDK)
Abivax Sa Sponsored Ads (ABVX)
Johnson & Johnson (JNJ)
Brightspring Health Svcs (BTSG)
Viking Therapeutics Call Call Option
Viking Therapeutics (VKTX)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Nebius Group Shs Class A (NBIS)

View all positions for Persistent Asset Partners

Top funds holding Aytu Biopharma

Nantahala Capital Management
Stonepine Capital Management
AWM Investment Company
Diadema Partners
Vanguard Group
Renaissance Technologies
Persistent Asset Partners
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Dimensional Fund Advisors
FNY Investment Advisers
DRW Holdings
XTX Topco
Bellevue Asset Management

View all funds holding Aytu Biopharma